Immunogenicity of a yeast-derived hepatitis B vaccine in hemodialysis patients.
暂无分享,去创建一个
[1] A. Safary,et al. Clinical experience with a yeast-derived hepatitis B vaccine. , 1989, Journal of chemotherapy.
[2] W. Szmuness,et al. Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. , 1984, The New England journal of medicine.
[3] P. Jungers,et al. Hepatitis B vaccine: randomized trial of immunogenicity in hemodialysis patients. , 1984, Clinical nephrology.
[4] J. Colaert,et al. EFFICACY OF HEAT-INACTIVATED HEPATITIS B VACCINE IN HAEMODIALYSIS PATIENTS AND STAFF Double-blind Placebo-controlled Trial , 1983, The Lancet.
[5] U. Binswanger,et al. Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients. , 1983, Antiviral research.
[6] P. Jungers,et al. RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: II, HAEMODIALYSIS PATIENTS , 1981, The Lancet.
[7] A. Neurath,et al. Prevalence of hepatitis B "e" antigen and its antibody in various HBsAg carrier populations. , 1981, American journal of epidemiology.
[8] M. Rothstein,et al. Duration of hepatitis B surface antigenemia (HBs Ag) in hemodialysis patients. , 1979, Archives of internal medicine.
[9] J. Sobczyk. [Immune response in uremia]. , 1978, Polski tygodnik lekarski.
[10] D. Snydman,et al. Hemodialysis-Associated Hepatitis in the United States, 1974 , 1977 .
[11] M. K. Mann,et al. Hepatitis B infection. A point-prevalence study in 15 US hemodialysis centers. , 1974 .
[12] J. Maynard,et al. Serological and epidemiological studies of hepatitis B in haemodialysis units. , 1973, Lancet.
[13] M. Rambausek,et al. Vaccination against hepatitis B in patients with renal insufficiency. , 1985, Proceedings of the European Dialysis and Transplant Association.
[14] J. Hoofnagle,et al. Viral hepatitis and liver disease , 1984 .
[15] G. Hess,et al. Hepatitis B virus markers in 97 long-term hemodialysis patients. , 1979, Nephron.